Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interactions in epilepsy.

M J Brodie1

  • 1University Department of Medicine & Therapeutics, Western Infirmary, Glasgow, Scotland.

Epilepsia
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Most epilepsy patients achieve seizure control with one antiepileptic drug. However, polypharmacy often leads to unpredictable drug interactions, impacting efficacy and increasing risks. Future treatments may involve synergistic combinations for better outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perampanel for focal epilepsy: insights from early clinical experience.

Acta neurologica Scandinavica·2015
Same author

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

Acta neurologica Scandinavica. Supplementum·2012
Same author

Patterns of treatment response in newly diagnosed epilepsy.

Neurology·2012
Same author

Adjunctive pregabalin for uncontrolled partial-onset seizures: findings from a prospective audit.

Acta neurologica Scandinavica·2011
Same author

Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions.

Biochemical pharmacology·2010
Same author

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.

Neurology·2010
Same journal

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same journal

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
Same journal

Vagus nerve stimulation for patients with tuberous sclerosis complex-related drug-resistant epilepsy: A prospective cohort study.

Epilepsia·2026
Same journal

Semiology of functional/dissociative seizures in idiopathic generalized epilepsy: An inpatient video-electroencephalographic study.

Epilepsia·2026
Same journal

Perineuronal net abnormalities in epileptic human tissue.

Epilepsia·2026
Same journal

Cortical stimulation reveals effective disconnection of the epileptogenic network at seizure onset.

Epilepsia·2026
See all related articles

Area of Science:

  • Pharmacology
  • Neuroscience
  • Clinical Pharmacy

Background:

  • Epilepsy treatment often requires single antiepileptic drugs (AEDs), with over 80% achieving seizure control.
  • A significant portion of patients require polypharmacy, with limited benefit (around 10%) and a high incidence of drug interactions.
  • Common AEDs like carbamazepine and phenytoin are enzyme inducers, accelerating metabolism of other drugs, while valproate is a minor inhibitor.

Purpose of the Study:

  • To review the complexities of antiepileptic drug interactions in epilepsy management.
  • To highlight pharmacokinetic and pharmacodynamic interactions associated with AED polypharmacy.
  • To discuss the impact of drug interactions on cognitive function, teratogenesis, and new drug assessment.

Main Methods:

Related Experiment Videos

  • Literature review of pharmacokinetic and pharmacodynamic interactions of antiepileptic drugs.
  • Analysis of enzyme induction and inhibition properties of common AEDs.
  • Examination of clinical consequences of AED polypharmacy, including cognitive and teratogenic effects.

    • Main Results:

    • Enzyme-inducing AEDs accelerate the metabolism of co-prescribed drugs, reducing their efficacy.
    • Pharmacokinetic interactions are common and unpredictable with AED combinations.
    • Pharmacodynamic interactions, such as those with psychoactive drugs and ethanol, can worsen seizure control.
    • AED polypharmacy is associated with impaired cognitive function and increased teratogenic risk in pregnancy.
    • Drug interactions complicate the assessment of new antiepileptic drugs.

    Conclusions:

    • Current approaches to intractable epilepsy lack a rational basis for polypharmacy.
    • Understanding and managing drug interactions is crucial for optimizing epilepsy treatment.
    • Synergistic combinations of new AEDs with single mechanisms of action hold promise for revolutionizing epilepsy management.